Contemporary practice in Europe: outcomes of patients with MDS enrolled in the EBMT registry and allografted between 2010 and 2020. Kaplan-Meier curves show OS outcomes of patients with MDS in the time periods 2010 to 2015 and 2016 to 2020 according to the age at allo-HCT (A), type of donor (B), and conditioning regimen intensity (C). Numbers at risk are indicated below the curves and color-coded. Table below each curve provides OS estimates at 24 and 48 months; median follow-up for the entire cohort is 49 months (95% confidence interval, 48-50). CB, cord blood; Haplo, haploidentical; MMUD, mismatched unrelated donor; MRD, matched related donor; MUD, matched unrelated donor.

Contemporary practice in Europe: outcomes of patients with MDS enrolled in the EBMT registry and allografted between 2010 and 2020. Kaplan-Meier curves show OS outcomes of patients with MDS in the time periods 2010 to 2015 and 2016 to 2020 according to the age at allo-HCT (A), type of donor (B), and conditioning regimen intensity (C). Numbers at risk are indicated below the curves and color-coded. Table below each curve provides OS estimates at 24 and 48 months; median follow-up for the entire cohort is 49 months (95% confidence interval, 48-50). CB, cord blood; Haplo, haploidentical; MMUD, mismatched unrelated donor; MRD, matched related donor; MUD, matched unrelated donor.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal